The new Regulation 2017/745 (EU) on Medical Devices (MDR) imposes strict demands on medical device manufacturers, Notified Bodies, and extends the scope also to the pharmaceutical industry related to medicinal substances with an integral medical device. Article 117 of the MDR amends the Directive 2001/83/EC, point 12 of Section 3.2 and requests for (single) integral products the involvement of a notified body to assess the conformity of the device part with the relevant general safety and performance requirements (GSPR) of Annex I and to issue a so-called “Notified Body Opinion”. This webinar will highlight the current experience with the new obligations, and the necessary steps to obtain a Notified Body Opinion.
Learn the impact of Article 117 on the concentrated product portfolio
Understand key general safety and performance requirements
Prepare your document for submission
Ms. Julia Frese
Division Head of Medical Services and Health Services, TÜV SÜD Japan
Julia is a biomedical engineer with a Master degree in Business Administration. Julia gained experience in development, regulatory approval of combination devices and ATMP products. She was also involved in the development of standards for ATMP products.
Currently, Julia is heading the division of Medical and Health Services at TÜV SÜD Japan and is responsible for the development of Article 117 service within the organisation. She is also the co-chair of Team NB working group for Article 117.